Similar to the analysis conducted in MDD, the DCGL software package identified three putative DRGs (termed DRGSSD-pre that included FOSB, PATZ1, and TFAP4) and 10 putative TF2target DCLs (termed DRLSSD-pre that are displayed in Table 3) between pre-treatment SSD and healthy control samples. This evidence concerns the gene TFAP4 and major depressive disorder.